Goode, PhD, President & Chief Executive Officer of Glucotrack. "With these positive ... device related serious adverse events reported from implant through seven days post-removal of the CBGM ...
Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology RUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) ...
RUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people ...
(MENAFN- GlobeNewsWire - Nasdaq) Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology RUTHERFORD ...
RUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and ...
Glucotrack (GCTK),announced that Guillermo Umpierrez, MD, CDCES, FACE, MACP, has been named as Glucotrack’s new Medical Advisory Board member, effective immediately. See what stocks are ...
In February 2025, a rumor spread online that Elon Musk, the technology mogul and public face of the new Department of Government Efficiency under U.S. President Donald Trump, has a penile implant. S ...
DETROIT, MICHIGAN - February 25, 2025 (NEWMEDIAWIRE) - Glucotrack, Inc. (NASDAQ: GCTK) reports it has achieved a significant milestone in its mission to transform diabetes management through three ...
Glucotrack, Inc. GCTK reports it has achieved a significant milestone in its mission to transform diabetes management through three distinct advances: direct blood glucose measurement, hassle-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results